| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 52.31B | 51.71B | 42.67B | 37.26B | 35.19B | 27.52B |
| Gross Profit | 8.21B | 8.05B | 7.08B | 7.00B | 5.63B | 5.34B |
| EBITDA | 3.03B | 2.86B | 2.34B | 3.03B | 2.26B | 2.07B |
| Net Income | 1.53B | 1.39B | 1.11B | 1.58B | 1.22B | 1.17B |
Balance Sheet | ||||||
| Total Assets | 55.49B | 54.51B | 48.45B | 43.44B | 31.98B | 27.96B |
| Cash, Cash Equivalents and Short-Term Investments | 8.04B | 6.90B | 8.90B | 6.82B | 7.91B | 5.19B |
| Total Debt | 39.65B | 38.38B | 32.40B | 28.81B | 20.06B | 16.94B |
| Total Liabilities | 43.96B | 43.23B | 37.99B | 33.87B | 23.76B | 20.81B |
| Stockholders Equity | 11.43B | 11.18B | 10.36B | 9.48B | 8.15B | 7.15B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -7.36B | -742.99M | -9.38B | 52.79M | -178.56M |
| Operating Cash Flow | 0.00 | -7.31B | -691.23M | -9.31B | 127.48M | 236.66M |
| Investing Cash Flow | 0.00 | -102.32M | -359.91M | -285.83M | 28.19M | -578.20M |
| Financing Cash Flow | 0.00 | 5.39B | 3.13B | 8.50B | 2.56B | 823.21M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥21.97B | 12.03 | ― | 4.36% | 1.52% | 16.04% | |
76 Outperform | ¥21.63B | -32.07 | ― | 3.54% | 36.88% | 83.47% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | ¥57.04B | 9.84 | ― | 0.45% | -8.33% | -36.89% | |
56 Neutral | ¥33.50B | 7.38 | ― | 6.11% | 81.19% | 250.41% | |
56 Neutral | ¥19.09B | 5.83 | ― | ― | 23.19% | 44.46% | |
44 Neutral | ¥23.24B | 77.48 | ― | 2.89% | 6.24% | 64.65% |